Daria Terentyeva

Ms. Daria Terentyeva

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2024 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Olga SindeevaOlga Sindeeva
Olga Sindeeva
PDPolina A. Demina
Polina A. Demina
ZKZhanna Kozyreva
Zhanna Kozyreva
DTDaria Terentyeva
Daria Terentyeva
OGOlga I. Gusliakova
Olga I. Gusliakova
Gleb SukhorukovGleb Sukhorukov
Gleb Sukhorukov
Reliable cell labeling and tracking techniques are imperative for elucidating the intricate and ambiguous interactions between mesenchymal stromal cells (MSCs) and tumors. Here, we explore fluorescent photoconvertible nanoengineered vesicles to study mMSC migration in brain tumors. These 3 μm sized vesicles made of carbon nanoparticles, Rhodamine B (RhB), and polyelectrolytes are readily internalized by cells. The dye undergoes photoconversion under 561 nm laser exposure with a fluorescence blue shift upon demand. The optimal laser irradiation duration for photoconversion was 0.4 ms, which provided a maximal blue shift of the fluorescent signal label without excessive laser exposure on cells. Vesicles modified with an extra polymer layer demonstrated enhanced intracellular uptake without remarkable effects on cell viability, motility, or proliferation. The optimal ratio of 20 vesicles per mMSC was determined. Moreover, the migration of individual mMSCs within 2D and 3D glioblastoma cell (EPNT-5) colonies over 2 days and in vivo tumor settings over 7 days were traced. Our study provides a robust nanocomposite platform for investigating MSC–tumor dynamics and offers insights into envisaged therapeutic strategies. Photoconvertible vesicles also present an indispensable tool for studying complex fundamental processes of cell–cell interactions for a wide range of problems in biomedicine.

5 May 2024 in Heliyon
Verified
Journal Article
Open access
ZKZhanna Kozyreva
Zhanna Kozyreva
PDPolina A. Demina
Polina A. Demina
ASAnastasiia Yu Sapach
Anastasiia Yu Sapach
DTDaria Terentyeva
Daria Terentyeva
OGOlga I. Gusliakova
Olga I. Gusliakova
Olga SindeevaOlga Sindeeva
Olga Sindeeva
Tracing individual cell pathways among the whole population is crucial for understanding their behavior, cell communication, migration dynamics, and fate. Optical labeling is one approach for tracing individual cells, but it typically requires genetic modification to induce the generation of photoconvertible proteins. Nevertheless, this approach has limitations and is not applicable to certain cell types. For instance, genetic modification often leads to the death of macrophages. This study aims to develop an alternative method for labeling macrophages by utilizing photoconvertible micron-sized capsules capable of easy internalization and prolonged retention within cells. Thermal treatment in a polyvinyl alcohol gel medium is employed for the scalable synthesis of capsules with a wide range of fluorescent dyes, including rhodamine 6G, pyronin B, fluorescein, acridine yellow, acridine orange, thiazine red, and previously reported rhodamine B. The fluorescence brightness, photostability, and photoconversion ability of the capsules are evaluated using confocal laser scanning microscopy. Viability, uptake, mobility, and photoconversion studies are conducted on RAW 264.7 and bone marrow-derived macrophages, serving as model cell lines. The production yield of the capsules is increased due to the use of polyvinyl alcohol gel, eliminating the need for conventional filtration steps. Capsules entrapping rhodamine B and rhodamine 6G meet all requirements for intracellular use in individual cell tracking. Mass spectrometry analysis reveals a sequence of deethylation steps that result in blue shifts in the dye spectra upon irradiation. Cellular studies on macrophages demonstrate robust uptake of the capsules. The capsules exhibit minimal cytotoxicity and have a negligible impact on cell motility. The successful photoconversion of RhB-containing capsules within cells highlights their potential as alternatives to photoconvertible proteins for individual cell labeling, with promising applications in personalized medicine.

12 December 2023 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Anastasiia MerdalimovaAnastasiia Merdalimova
Anastasiia Merdalimova
RBRoman Barmin
Roman Barmin
VVViktor Vorobev
Viktor Vorobev
AAArtem Aleksandrov
Artem Aleksandrov
DTDaria Terentyeva
Daria Terentyeva
Dmitry GorinDmitry Gorin
Dmitry Gorin

21 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Olga SindeevaOlga Sindeeva
Olga Sindeeva
PDPolina A. Demina
Polina A. Demina
ZKZhanna Kozyreva
Zhanna Kozyreva
DTDaria Terentyeva
Daria Terentyeva
OGOlga I. Gusliakova
Olga I. Gusliakova
Gleb SukhorukovGleb Sukhorukov
Gleb Sukhorukov
To elucidate mesenchymal stromal cells (MSC)-tumor intricate and ambiguous interactions, the reliable cell labeling and tracking techniques are imperative. Traditional methods of cell labelling have limitations mostly relevant to need for genetic modification what demands the exploration for alternative strategies. Here, we propose using fluorescent photoconvertible microcapsules containing Rhodamine B (RhB) to study mMSC migration in brain tumors. These 3 μm sized microcapsules are readily internalised by cells and undergo photoconversion under 561 nm laser exposure with fluorescence blue shift on demand. Optimal photoconversion was achieved with a laser irradiation duration of 0.4 ms, which provide a maximal brightness of photoconverted label without an excessive laser exposure on cells. Capsules modified with polyallylamine hydrochloride demonstrated the best potential for intracellular uptake without significantly affecting cell viability, motility, or proliferation. The optimal ratio of 20 capsules per mMSC was determined for labeling. Moreover, migration of individual mMSCs within 2D and 3D glioblastoma cell (EPNT-5) colonies over 2 days and in vivo tumor settings over 7 days was tracked. Our study unveils a robust platform for investigating MSC-tumor dynamics, offering insights into therapeutic strategies. Photoconvertible microcapsules could also become an indispensable tool for studying complex fundamental processes of cell-cell interactions for a wide range of problems in biology and medicine.

9 January 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Olga SindeevaOlga Sindeeva
Olga Sindeeva
LKLyubov I. Kazakova
Lyubov I. Kazakova
ASAlexandra Sain
Alexandra Sain
OGOlga I. Gusliakova
Olga I. Gusliakova
OKOleg Alexandrovich Kulikov
Oleg Alexandrovich Kulikov
Gleb SukhorukovGleb Sukhorukov
Gleb Sukhorukov
Background: While intravenous administration of nanoparticles (NPs) is effective for targeting the lungs and liver, directing them to other organs and tissues remains challenging. Methods: Here, we report alternative administration routes that improve organ-specific accumulation of poly (lactic-co-glycolic acid) (PLGA) NPs (100 nm, negatively charged) loaded with the near-infrared dye Cyanine 7 (Cy7). NP cytotoxicity was evaluated in HEK293, mMSCs, C2C12, L929, and RAW264.7 cells. Hemocompatibility was assessed using WBCs and RBCs. NPs were administered via the tail vein, carotid, renal, and femoral arteries in BALB/c mice. Administration safety was evaluated by laser speckle contrast imaging and histological analysis. NP biodistribution and accumulation were assessed using in vivo and ex vivo fluorescence tomography and confocal microscopy of cryosections. Results: PLGA-Cy7 NPs demonstrate low cytotoxicity even at high doses and exhibit good hemocompatibility. Administration of NPs through the mouse carotid, renal, and femoral arteries significantly increases accumulation in the target ipsilateral brain hemisphere (31.7-fold) and salivary glands (28.3-fold), kidney (13.7-fold), and hind paw (3.6-fold), respectively, compared to intravenous administration. Injection of NPs through arteries supplying the target organs and tissues does not result in significant changes in blood flow, morphological alterations, or irreversible embolization of vessels, provided the procedure is performed correctly and the optimal dosage is used. Conclusions: These results highlight the potential of intra-arterial delivery of NPs for organ-specific drug targeting, underscoring the synergistic impact of advances in materials science, minimally invasive endovascular surgery, and nanomedicine.

1 January 2026 in Light: Advanced Manufacturing
Verified
Journal Article
Open access
PDF file
DTDaria Terentyeva
Daria Terentyeva
ZKZhanna V. Kozyreva
Zhanna V. Kozyreva
OGOlga I. Gusliakova
Olga I. Gusliakova
PDPolina A. Demina
Polina A. Demina
AKAnton D. Kosov
Anton D. Kosov
Olga SindeevaOlga Sindeeva
Olga Sindeeva
Photodynamic therapy (PDT) is a promising strategy for treating solid tumours due to its spatially controlled, lighttriggered cytotoxicity. Although recent advances in optical technologies have improved light delivery, PDT efficacy remains limited by insufficient drug accumulation in tumours, largely due to the complexity of the tumour microenvironment. To address this challenge, a macrophage-mediated delivery platform was developed using layer-by-layer (LbL) microcapsules loaded with second-generation photosensitizers: photoditazine (PD) and aluminum tetrasulfophthalocyanine chloride (PS). Both photosensitizers exhibited low dark toxicity and high phototoxicity, enabling their safe transport by carrier cells. The photosensitizers were efficiently encapsulated into LbL microcapsules (6.2 ± 0.5 μm) with different shell compositions. Significant differences were observed between macrophage types: RAW 264.7 macrophages predominantly retained capsules on the cell surface, whereas primary peritoneal macrophages (PMs) internalised capsules within 3 h and retained them for up to 6 d without degradation. Among the tested formulations, polyarginine/dextran sulfate ((PArg/DS) 4) capsules loaded with PD demonstrated the highest uptake efficiency and supported macrophage migration into tumour spheroids. In vivo experiments using a CT-26 colon cancer model confirmed the therapeutic potential of this platform, while highlighting the need for further optimisation for large tumours. This study provides new insights into cellmediated delivery systems and underscores their potential to enhance PDT outcomes beyond current limitations.